Fluctuation of insulin resistance in a leprechaun with a primary defect in insulin binding

Masashi Kobayashi*, Yasumitsu Takata, Toshiyasu Sasaoka, Yukio Shigeta, Katsumi Goji

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Abstract

A 3-month-old female leprechaun demonstrated extreme insulin resistance with hyperinsulinemia (330 μmol/L) and resistance to exogenous insulin. Insulin binding to erythrocytes, cultured lymphocytes, and fibroblasts from the patient were decreased to less than 20% of normal, whereas insulin-like growth factor I binding to fibroblasts was normal. Antiinsulin receptor antibody binding to cultured lymphocytes was also decreased to 20% of normal, indicating a decreased concentration of insulin receptors on the cell surface. The ability of insulin to stimulate D-[14C]glucose uptake was decreased to 35% of normal in the patient’ s fibroblasts, and the dose-response curve was shifted to the right. With time, the insulin resistance fluctuated from near normal (fasting insulin, 244.0 pmol/L) to severe resistance (fasting insulin, 5740-9328 pmol/L), and an insulin tolerance test revealed amelioration of insulin resistance during remission. However, insulin binding to erythrocytes and adipocytes was decreased persistently to 20% of normal. These results indicate that the patient had a primary defect in her insulin receptors, i.e. decreased insulin receptor concentration. The variable degree of insulin resistance was possibly due to variable receptor function in the signal transmission process.

Original languageEnglish
Pages (from-to)1084-1088
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Volume66
Issue number5
DOIs
StatePublished - 1988/05

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Fingerprint

Dive into the research topics of 'Fluctuation of insulin resistance in a leprechaun with a primary defect in insulin binding'. Together they form a unique fingerprint.

Cite this